Teva to Acquire Labrys Biologics, Inc
June 03, 2014 at 07:32 AM EDT
June 3, 2014 11:30:00 UTC Adds LBR-101, Labrys' Phase IIb anti-CGRP monoclonal antibody for the prevention of chronic and high ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.